Navigation Links
EntreMed's ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
Date:10/23/2008

ROCKVILLE, Md., Oct. 23 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the presentation of preclinical data for its Aurora A/angiogenesis kinase inhibitor, ENMD-2076. The data were presented by John Tentler, Ph.D., Division of Medical Oncology, University of Colorado, at the 20th EORTC-NCI-AACR Annual Meeting being held this week in Geneva, Switzerland.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

ENMD-2076 is a novel kinase inhibitor with potent activity against Aurora A and a number of tyrosine kinases linked to cancer and inflammatory diseases. ENMD-2076 demonstrated strong antitumor effects in a xenograft model of human colon cancer. Tumor stasis was seen at dose levels of 100 mg/kg/day, and tumor regression was observed at doses of 200 mg/kg ENMD-2076 per day. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and post-study histological examination of tumors suggest that the antitumor effects of ENMD-2076 are exerted through a combination of antiangiogenic and antiproliferative actions. Further analysis using positron emission tomography (PET) demonstrated a substantial decrease in tumor metabolic activity in animals treated with ENMD-2076.

ENMD-2076 exerts its effects through multiple mechanisms of action, including antiproliferative activity and the inhibition of angiogenesis. ENMD-2076 has demonstrated substantial dose-dependent efficacy as a single agent, including tumor regression, in multiple xenograft models (e.g. breast, colon, leukemia). Aurora kinase
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. EntreMeds Kinase Inhibitor, ENMD-2076, Presented During AACR Special Session
2. EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
3. SuperGens MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy
4. SAFC Hitech(TM) Successfully Demonstrates Device-Quality GST Precursors For Phase Change Memory Applications
5. Grid Dynamics Demonstrates Linear Scalability up to 512 Nodes with GridGain Software on Amazon EC2 Cloud
6. First semiconductor-based PET scanner demonstrates potential to aid in early diagnosis of disease
7. SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)
8. ASCO 2008: Tumor-Targeted Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Metastatic Pancreatic Cancer
9. Oral PBI-1402 Demonstrates Significant Activity in Chemotherapy-Induced Anemia Phase II Clinical Trial
10. ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study
11. Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiologys Toughest Questions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2009)...v. 7, Research projects in the are...s this evening, as Tim Kunisky of Livingston, NJ a...of Audubon, PA received the highest honors at the ... in Math, Science & Technology, the nation,s p...ttp://www.newscom.com/cgi-bin/prnh/20070904/SIEMEN...
(Date:11/6/2009)...6 Myriant Technologies LLC ("Myria...facturer of renewable bio-chemicals, Uhde Corpora...der Uhde GmbH, one of the world,s leading engineer...iance for the engineering, procurement & const...plants based on renewable feedstocks. The executi...
(Date:11/6/2009)...ewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:...today announced updated results from a Phase II st...rcomas metastatic to the lung in a poster presenta... Society Meeting held in Miami Beach, Florida, fro...titled "A Phase II Study of Intravenous REOLYSIN (...
(Date:11/5/2009)...ov. 5 GenVec, Inc. (Nasd...for the third quarter ended September 30, 2009. Ge...r share) for the three months ended September 30, ... per share) in the comparable quarter of 2008. For...s net loss was $14.1 million ($0.15 per share), co...
Breaking Biology Technology:Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
...n. Remember that word? It was as popular in Web ci...tain vendor circles. The long and short of it was ...nd let suppliers sell directly to consumers, eithe... loop would take a slice of the middle-mans cut, s...sumers. A real win-win situation as long as you di...
...ic stem-cell research, policymakers and investors ... answer is no. But among those states poised to co...onsin may be the best positioned for success. , ,T... Gov. Jim Doyle is not aimed at advancing stem-cel...sciences that may yield advances across a much bro...
...ike the roads and all the highways. Somehow there ... some drive taxis, others drive Ferraris orrace tr... and so are the maps. Thank heaven. , ,This brings...nternet ever so underutilized and why is 90 percen...s it because this highway is considered free and t...
Other Biology Technology:A funny thing happened on the way out of the back office 2A funny thing happened on the way out of the back office 3Life-science research plan is about more than stem cells 2Life-science research plan is about more than stem cells 3Global Internet branding of technology companies 2Global Internet branding of technology companies 3
(Date:11/6/2009)...lly live in harmony with their arboreal hosts. But...pace in their trees of choice, the ants can get de...published in the November issue of the American N...e into live trees, and it reopens a centuries-old .... , Ants and certain species of plants and trees...
(Date:11/5/2009)...of Biology Teachers (NABT) will recognize Leonard ...Naugatuck Valley Community College (NVCC) in Water...on Award during the NABT annual professional devel...n Denver, Colorado. , The Evolution Education Aw...ological Sciences,(AIBS) and Biological Sciences ...
(Date:11/4/2009)...ientists are reluctant to officially endorse green...nues to grow about its protective effects, includi...vention Research , a journal of the American Assoc...duction in oral cancer. , Vassiliki Papadimitra...ment of Thoracic/Head and Neck Medical Oncology at...
Breaking Biology News(10 mins):Ants are friendly to some trees, but not others 2Biologists, educators recognize excellence in evolution education 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2Scholar unconvinced new lie detection methods better than old ones 8689 1Scholar unconvinced new lie detection methods better than old ones 8689 2Scholar unconvinced new lie detection methods better than old ones 8689 3Scholar unconvinced new lie detection methods better than old ones 8689 4ClearTrial to Chair Session at DIA 45th Annual Meeting on 26quot 3BEffective Operational Planning for Adaptive Clinical Trials 26quot 3B 12415 1ClearTrial to Chair Session at DIA 45th Annual Meeting on 26quot 3BEffective Operational Planning for Adaptive Clinical Trials 26quot 3B 12415 2ClearTrial to Chair Session at DIA 45th Annual Meeting on 26quot 3BEffective Operational Planning for Adaptive Clinical Trials 26quot 3B 12415 3Kashi Company Debuts Heart to Heart 28TM 29 Whole Grain Crackers 47606 1Kashi Company Debuts Heart to Heart 28TM 29 Whole Grain Crackers 47606 2Kashi Company Debuts Heart to Heart 28TM 29 Whole Grain Crackers 47606 3
...TC Bulletin Board: STIY), a leader in electro-stun... Sheriff,s Office (CCSO) Caldwell, ID has,purchase...Device. CCSO is a,329-man department., Lt. Daren ... product,and was seeking alternatives that would b... these tough times, budget of course is an importa...
...w online magazine dedicated to covering the global...ale.edu . Edited by Roger Cohn, the former editor ...nment 360 aims to become one of the leading Web si...vironmental issues of the day. , The magazine,s i...nmental advocate and author, Bill McKibben; New Yo...
... for scientific know-how than in finding new ways ...ices, an uncertain oil supply, increasing demand f...imate change have made identifying and developing ... , For Biodesign Institute researcher Bruce Ritt... significant opportunity for innovation and fresh ...
Other Biology News:Canyon County Idaho Sheriff's Office to Purchase Stinger S-200s 2Yale Environment 360 magazine launches online 2Biodesign's Rittmann offers promising perspectives on society's energy challenge 2Biodesign's Rittmann offers promising perspectives on society's energy challenge 3
Cassette, Xba I from Takara Mirus Bio
Cassette, Hind III from Takara Mirus Bio
DryStrip aligners from GE Healthcare, formerly Amersham Biosciences
Cassette, Sal I from Takara Mirus Bio
Biology Products: